| Missing Links?: 1093 Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 10146,
Authors: 16970,
Journals: 1137,
Outer References: 208320,
Words: 13772
Collection span: 1949 - 2005
View: Overview. Sorted by journal name.
Page 24 of 102: 1 11 [ 21 22 23 24 25 26 27 28 29 30 ] 31 41 51 61 71 81 91 | 101
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 2301 | 8 | 22 | 7219 1985 CANCER RESEARCH 45 (8): 3642-3645 KEYES SR; ROCKWELL S; SARTORELLI AC PORFIROMYCIN AS A BIOREDUCTIVE ALKYLATING AGENT WITH SELECTIVE TOXICITY TO HYPOXIC EMT6 TUMOR-CELLS INVIVO AND INVITRO | 34 | 68 |
| 2302 | 3 | 35 | 7220 1985 CANCER RESEARCH 45 (9): 4178-4184 PLOOY ACM; VANDIJK M; BERENDS F; LOHMAN PHM FORMATION AND REPAIR OF DNA INTERSTRAND CROSS-LINKS IN RELATION TO CYTO-TOXICITY AND UNSCHEDULED DNA-SYNTHESIS INDUCED IN CONTROL AND MUTANT HUMAN-CELLS TREATED WITH CIS-DIAMMINEDICHLOROPLATINUM(II) | 1 | 120 |
| 2303 | 3 | 38 | 7221 1985 CANCER RESEARCH 45 (9): 4553-4558 GONDA MA; WONGSTAAL F; GALLO RC; CLEMENTS JE; GILDEN RV HETERODUPLEX MAPPING IN THE MOLECULAR ANALYSIS OF THE HUMAN T-CELL LEUKEMIA (LYMPHOTROPIC) VIRUSES | 0 | 3 |
| 2304 | 6 | 26 | 7222 1985 CANCER RESEARCH 45 (11): 5281-5286 WILLSON JKV; LONG BH; CHAKRABARTY S; BRATTAIN DE; BRATTAIN MG EFFECTS OF BMY 25282, A MITOMYCIN-C ANALOG, IN MITOMYCIN C-RESISTANT HUMAN-COLON CANCER-CELLS | 9 | 32 |
| 2305 | 6 | 46 | 7223 1985 CANCER RESEARCH 45 (11): 5399-5404 GRUENERT DC; CLEAVER JE REPAIR OF PSORALEN-INDUCED CROSS-LINKS AND MONOADDUCTS IN NORMAL AND REPAIR-DEFICIENT HUMAN-FIBROBLASTS | 0 | 49 |
| 2306 | 4 | 16 | 7224 1985 CANCER RESEARCH 45 (11): 5939-5943 MARSHALL RS; ERLICHMAN C; RAUTH AM A BIOASSAY TO MEASURE CYTO-TOXICITY OF PLASMA FROM PATIENTS TREATED WITH MITOMYCIN-C | 3 | 5 |
| 2307 | 10 | 24 | 7456 1986 CANCER RESEARCH 46 (6): 2709-2713 MARSHALL RS; RAUTH AM MODIFICATION OF THE CYTOTOXIC ACTIVITY OF MITOMYCIN-C BY OXYGEN AND ASCORBIC-ACID IN CHINESE-HAMSTER OVARY CELLS AND A REPAIR-DEFICIENT MUTANT | 16 | 59 |
| 2308 | 3 | 38 | 7457 1986 CANCER RESEARCH 46 (6): 2784-2792 ETTINGHAUSEN SE; ROSENBERG SA IMMUNOTHERAPY OF MURINE SARCOMAS USING LYMPHOKINE ACTIVATED KILLER-CELLS - OPTIMIZATION OF THE SCHEDULE AND ROUTE OF ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 | 0 | 132 |
| 2309 | 11 | 28 | 7458 1986 CANCER RESEARCH 46 (6): 2883-2887 RUSSELL KJ; RICE GC; BROWN JM INVITRO AND INVIVO RADIATION SENSITIZATION BY THE HALOGENATED PYRIMIDINE 5-CHLORO-2'-DEOXYCYTIDINE | 2 | 9 |
| 2310 | 5 | 14 | 7459 1986 CANCER RESEARCH 46 (7): 3456-3458 CHAKRABARTY S; DANELS YJ; LONG BH; WILLSON JKV; BRATTAIN MG CIRCUMVENTION OF DEFICIENT ACTIVATION IN MITOMYCIN C-RESISTANT HUMAN COLONIC-CARCINOMA CELLS BY THE MITOMYCIN-C ANALOG BMY25282 | 7 | 20 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2311 | 9 | 32 | 7460 1986 CANCER RESEARCH 46 (7): 3528-3532 PRITSOS CA; SARTORELLI AC GENERATION OF REACTIVE OXYGEN RADICALS THROUGH BIOACTIVATION OF MITOMYCIN ANTIBIOTICS | 34 | 135 |
| 2312 | 24 | 53 | 7461 1986 CANCER RESEARCH 46 (8): 3939-3944 FRACASSO PM; SARTORELLI AC CYTOTOXICITY AND DNA LESIONS PRODUCED BY MITOMYCIN-C AND PORFIROMYCIN IN HYPOXIC AND AEROBIC EMT6 AND CHINESE-HAMSTER OVARY CELLS | 23 | 60 |
| 2313 | 5 | 44 | 7462 1986 CANCER RESEARCH 46 (10): 5276-5281 MOOLTEN FL TUMOR CHEMOSENSITIVITY CONFERRED BY INSERTED HERPES THYMIDINE KINASE GENES - PARADIGM FOR A PROSPECTIVE CANCER CONTROL STRATEGY | 1 | 670 |
| 2314 | 4 | 77 | 7463 1986 CANCER RESEARCH 46 (12): 6200-6206 MALEJKAGIGANTI D; RITTER CL; DECKER RW; SUILMAN JM PEROXIDATIVE METABOLISM OF A CARCINOGEN, N-HYDROXY-N-2-FLUORENYLACETAMIDE, BY RAT UTERUS AND MAMMARY-GLAND INVITRO | 0 | 19 |
| 2315 | 4 | 20 | 7464 1986 CANCER RESEARCH 46 (12): 6260-6263 FORESTI M; GAUDIO L; GERACI G; MANDUCA P INHIBITION OF DIMETHYLSULFOXIDE INDUCED ERYTHROPOIETIC DIFFERENTIATION OF MURINE ERYTHROLEUKEMIA-CELLS IN CULTURE | 0 | 8 |
| 2316 | 8 | 21 | 7465 1986 CANCER RESEARCH 46 (12): 6509-6512 BELANGER K; KLECKER RW; ROWLAND J; KINSELLA TJ; COLLINS JM INCORPORATION OF IODODEOXYURIDINE INTO DNA OF GRANULOCYTES IN PATIENTS | 22 | 32 |
| 2317 | 6 | 22 | 7676 1987 CANCER RESEARCH 47 (5): 1308-1312 WALLNER KE; BANDA M; LI GC HYPERTHERMIC ENHANCEMENT OF CELL KILLING BY MITOMYCIN-C IN MITOMYCIN-C-RESISTANT CHINESE-HAMSTER OVARY CELLS | 2 | 57 |
| 2318 | 6 | 57 | 7677 1987 CANCER RESEARCH 47 (9): 2363-2370 POWIS G; HODNETT EM; SANTONE KS; SEE KL; MELDER DC ROLE OF METABOLISM AND OXIDATION-REDUCTION CYCLING IN THE CYTOTOXICITY OF ANTITUMOR QUINONEIMINES AND QUINONEDIIMINES | 2 | 20 |
| 2319 | 6 | 15 | 7678 1987 CANCER RESEARCH 47 (21): 5654-5657 KEYES SR; ROCKWELL S; SARTORELLI AC CORRELATION BETWEEN DRUG UPTAKE AND SELECTIVE TOXICITY OF PORFIROMYCIN TO HYPOXIC EMT6 CELLS | 12 | 27 |
| 2320 | 36 | 68 | 7877 1988 CANCER RESEARCH 48 (4): 759-774 PEGG AE POLYAMINE METABOLISM AND ITS IMPORTANCE IN NEOPLASTIC GROWTH AND AS A TARGET FOR CHEMOTHERAPY | 0 | 1301 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2321 | 6 | 44 | 7878 1988 CANCER RESEARCH 48 (7): 1727-1735 BEGLEITER A; LEITH MK; MCCLARTY G; BEENKEN S; GOLDENBERG GJ; et al. CHARACTERIZATION OF L5178Y MURINE LYMPHOBLASTS RESISTANT TO QUINONE ANTITUMOR AGENTS | 9 | 36 |
| 2322 | 11 | 33 | 7879 1988 CANCER RESEARCH 48 (10): 2933-2937 SPETH PAJ; KINSELLA TJ; BELANGER K; KLECKER RW; SMITH R; et al. FLUORODEOXYURIDINE MODULATION OF THE INCORPORATION OF IODODEOXYURIDINE INTO DNA OF GRANULOCYTES - A PHASE-I AND CLINICAL PHARMACOLOGICAL STUDY | 13 | 27 |
| 2323 | 5 | 25 | 7880 1988 CANCER RESEARCH 48 (10): 2938-2941 YOSHII Y; SUGIYAMA K INTERCAPILLARY DISTANCE IN THE PROLIFERATING AREA OF HUMAN GLIOMA | 0 | 24 |
| 2324 | 4 | 28 | 7881 1988 CANCER RESEARCH 48 (15): 4244-4249 ACKLAND SP; SCHILSKY RL; BECKETT MA; WEICHSELBAUM RR SYNERGISTIC CYTO-TOXICITY AND DNA STRAND BREAK FORMATION BY BROMODEOXYURIDINE AND BLEOMYCIN IN HUMAN-TUMOR CELLS | 3 | 15 |
| 2325 | 5 | 28 | 7882 1988 CANCER RESEARCH 48 (18): 5172-5177 MASUDA K; NAKAMURA T; MIZOTA T; MORI J; SHIMOMURA K INTERSTRAND DNA-DNA AND DNA-PROTEIN CROSS-LINKS BY A NEW ANTITUMOR ANTIBIOTIC, FK973, IN L1210 CELLS | 6 | 37 |
| 2326 | 13 | 26 | 7883 1988 CANCER RESEARCH 48 (20): 5655-5659 MARSHALL RS; RAUTH AM OXYGEN AND EXPOSURE KINETICS AS FACTORS INFLUENCING THE CYTO-TOXICITY OF PORFIROMYCIN, A MITOMYCIN-C ANALOG, IN CHINESE-HAMSTER OVARY CELLS | 10 | 40 |
| 2327 | 2 | 32 | 7884 1988 CANCER RESEARCH 48 (20): 5805-5809 DESOMBRE ER; HARPER PV; HUGHES A; MEASE RC; GATLEY SJ; et al. BROMINE-80M RADIOTOXICITY AND THE POTENTIAL FOR ESTROGEN RECEPTOR-DIRECTED THERAPY WITH AUGER ELECTRONS | 0 | 22 |
| 2328 | 1 | 52 | 7885 1988 CANCER RESEARCH 48 (22): 6404-6410 GUPTA RS; GUPTA R; ENG B; LOCK RB; ROSS WE; et al. CAMPTOTHECIN-RESISTANT MUTANTS OF CHINESE-HAMSTER OVARY CELLS CONTAINING A RESISTANT FORM OF TOPOISOMERASE-I | 2 | 137 |
| 2329 | 15 | 31 | 7886 1988 CANCER RESEARCH 48 (23): 6900-6905 STETSON PL; MAYBAUM J; WAGNER JG; AVERILL DR; WOLLNER IS; et al. TISSUE-SPECIFIC PHARMACODYNAMICS OF 5-BROMO-2'-DEOXYURIDINE INCORPORATION INTO DNA IN VX2 TUMOR-BEARING RABBITS | 7 | 13 |
| 2330 | 5 | 44 | 8089 1989 CANCER RESEARCH 49 (2): 318-323 NAPALKOV NP; ANISIMOV VN; LIKHACHEV AJ; TOMATIS L 5-BROMODEOXYURIDINE-INDUCED CARCINOGENESIS AND ITS MODIFICATION BY PERSISTENT ESTRUS SYNDROME, UNILATERAL NEPHRECTOMY, AND X-IRRADIATION IN RATS | 4 | 28 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2331 | 5 | 53 | 8090 1989 CANCER RESEARCH 49 (3): 618-624 VAZQUEZPADUA MA; RISUENO C; FISCHER PH REGULATION OF THE ACTIVATION OF FLUORODEOXYURIDINE BY SUBSTRATE COMPETITION AND FEEDBACK INHIBITION IN 647V CELLS | 2 | 5 |
| 2332 | 3 | 54 | 8091 1989 CANCER RESEARCH 49 (9): 2415-2421 VAZQUEZPADUA MA; FISCHER PH; CHRISTIAN BJ; REZNIKOFF CA BASIS FOR THE DIFFERENTIAL MODULATION OF THE UPTAKE OF 5-IODODEOXYURIDINE BY 5'-AMINOTHYMIDINE AMONG VARIOUS CELL-TYPES | 3 | 8 |
| 2333 | 11 | 29 | 8092 1989 CANCER RESEARCH 49 (12): 3310-3313 KEYES SR; ROCKWELL S; SARTORELLI AC MODIFICATION OF THE METABOLISM AND CYTO-TOXICITY OF BIOREDUCTIVE ALKYLATING-AGENTS BY DICOUMAROL IN AEROBIC AND HYPOXIC MURINE TUMOR-CELLS | 15 | 42 |
| 2334 | 2 | 68 | 8093 1989 CANCER RESEARCH 49 (16): 4568-4577 PAWLAKBYCZKOWSKA EJ; HANSEN HJ; DION AS; GOLDENBERG DM 2 NEW MONOCLONAL-ANTIBODIES, EPB-1 AND EPB-2, REACTIVE WITH HUMAN LYMPHOMA | 0 | 61 |
| 2335 | 10 | 31 | 8291 1990 CANCER RESEARCH 50 (10): 2872-2876 BEGLEITER A; LEITH MK ACTIVITY OF QUINONE ALKYLATING-AGENTS IN QUINONE-RESISTANT CELLS | 3 | 19 |
| 2336 | 5 | 57 | 8292 1990 CANCER RESEARCH 50 (15): 4566-4571 MATTANO SS; PALELLA TD; MITCHELL BS MUTATIONS INDUCED AT THE HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE LOCUS OF HUMAN T-LYMPHOBLASTS BY PERTURBATIONS OF PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE POOLS | 0 | 32 |
| 2337 | 20 | 47 | 8293 1990 CANCER RESEARCH 50 (15): 4692-4697 HOBAN PR; WALTON MI; ROBSON CN; GODDEN J; STRATFORD IJ; et al. DECREASED NADPH - CYTOCHROME-P-450 REDUCTASE-ACTIVITY AND IMPAIRED DRUG ACTIVATION IN A MAMMALIAN-CELL LINE RESISTANT TO MITOMYCIN-C UNDER AEROBIC BUT NOT HYPOXIC CONDITIONS | 28 | 96 |
| 2338 | 12 | 37 | 8294 1990 CANCER RESEARCH 50 (16): 4962-4967 KUNUGI KA; VAZQUEZPADUA MA; MILLER EM; KINSELLA TJ MODULATION OF IDURD-DNA INCORPORATION AND RADIOSENSITIZATION IN HUMAN BLADDER-CARCINOMA CELLS | 6 | 18 |
| 2339 | 3 | 60 | 8295 1990 CANCER RESEARCH 50 (17): 5543-5550 PURI RK; TRAVIS WD; ROSENBERG SA INVIVO ADMINISTRATION OF INTERFERON-ALPHA AND INTERLEUKIN-2 INDUCES PROLIFERATION OF LYMPHOID-CELLS IN THE ORGANS OF MICE | 1 | 6 |
| 2340 | 24 | 51 | 8296 1990 CANCER RESEARCH 50 (23): 7483-7489 SIEGEL D; GIBSON NW; PREUSCH PC; ROSS D METABOLISM OF MITOMYCIN-C BY DT-DIAPHORASE - ROLE IN MITOMYCIN-C-INDUCED DNA DAMAGE AND CYTOTOXICITY IN HUMAN COLON-CARCINOMA CELLS | 44 | 194 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2341 | 3 | 37 | 8297 1990 CANCER RESEARCH 50 (23): 7513-7518 PARRIS CN; WALKER MC; MASTERS JRW; ARLETT CF INHERENT SENSITIVITY AND INDUCED RESISTANCE TO CHEMOTHERAPEUTIC DRUGS AND IRRADIATION IN HUMAN CANCER CELL-LINES - RELATIONSHIP TO MUTATION FREQUENCIES | 0 | 18 |
| 2342 | 6 | 23 | 8298 1990 CANCER RESEARCH 50 (24): 7789-7792 BLIGH HFJ; BARTOSZEK A; ROBSON CN; HICKSON ID; KASPER CB; et al. ACTIVATION OF MITOMYCIN-C BY NADPH-CYTOCHROME-P-450 REDUCTASE | 12 | 79 |
| 2343 | 14 | 29 | 8484 1991 CANCER RESEARCH 51 (3): 870-874 MANCINI WR; STETSON PL; LAWRENCE TS; WAGNER JG; GREENBERG HS; et al. VARIABILITY OF 5-BROMO-2'-DEOXYURIDINE INCORPORATION INTO DNA OF HUMAN GLIOMA CELL-LINES AND MODULATION WITH FLUOROPYRIMIDINES | 6 | 9 |
| 2344 | 20 | 33 | 8485 1991 CANCER RESEARCH 51 (15): 3900-3905 LAWRENCE TS; DAVIS MA; MCKEEVER PE; MAYBAUM J; STETSON PL; et al. FLUORODEOXYURIDINE-MEDIATED MODULATION OF IODODEOXYURIDINE INCORPORATION AND RADIOSENSITIZATION IN HUMAN COLON CANCER-CELLS INVITRO AND INVIVO | 9 | 32 |
| 2345 | 1 | 18 | 8486 1991 CANCER RESEARCH 51 (21): 5910-5914 NING SC; HAHN GM COMBINATION THERAPY - LONIDAMINE, HYPERTHERMIA, AND CHEMOTHERAPY AGAINST THE RIF-1 TUMOR INVIVO | 0 | 9 |
| 2346 | 17 | 41 | 8487 1991 CANCER RESEARCH 51 (24): 6622-6628 KRISHNA MC; DEGRAFF W; TAMURA S; GONZALEZ FJ; SAMUNI A; et al. MECHANISMS OF HYPOXIC AND AEROBIC CYTOTOXICITY OF MITOMYCIN-C IN CHINESE-HAMSTER V79 CELLS | 10 | 52 |
| 2347 | 13 | 23 | 8660 1992 CANCER RESEARCH 52 (3): 719-725 COOK JA; GLASS J; LEBOVICS R; BOBO H; PASS H; et al. MEASUREMENT OF THYMIDINE REPLACEMENT IN PATIENTS WITH HIGH-GRADE GLIOMAS, HEAD AND NECK TUMORS, AND HIGH-GRADE SARCOMAS AFTER CONTINUOUS INTRAVENOUS INFUSIONS OF 5-IODODEOXYURIDINE | 8 | 31 |
| 2348 | 21 | 35 | 8661 1992 CANCER RESEARCH 52 (13): 3698-3704 LAWRENCE TS; DAVIS MA; MAYBAUM J; MUKHOPADHYAY SK; STETSON PL; et al. THE POTENTIAL SUPERIORITY OF BROMODEOXYURIDINE TO IODODEOXYURIDINE AS A RADIATION SENSITIZER IN THE TREATMENT OF COLORECTAL-CANCER | 8 | 36 |
| 2349 | 26 | 45 | 8845 1993 CANCER RESEARCH 53 (21): 5127-5134 BIZANEK R; CHOWDARY D; ARAI H; KASAI M; HUGHES CS; et al. ADDUCTS OF MITOMYCIN-C AND DNA IN EMT6 MOUSE MAMMARY-TUMOR CELLS - EFFECTS OF HYPOXIA AND DICUMAROL ON ADDUCT PATTERNS | 30 | 50 |
| 2350 | 13 | 29 | 8846 1993 CANCER RESEARCH 53 (22): 5470-5474 GUSTAFSON DL; PRITSOS CA KINETICS AND MECHANISM OF MITOMYCIN-C BIOACTIVATION BY XANTHINE DEHYDROGENASE UNDER AEROBIC AND HYPOXIC CONDITIONS | 5 | 28 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2351 | 5 | 38 | 9021 1994 CANCER RESEARCH 54 (7): S1879-S1881 MILLER JA RECENT STUDIES ON THE METABOLIC-ACTIVATION OF CHEMICAL CARCINOGENS | 0 | 18 |
| 2352 | 16 | 31 | 9022 1994 CANCER RESEARCH 54 (8): 2121-2124 ENSMINGER WD; WALKER SC; STETSON PL; WAGNER JG; KNOL JA; et al. CLINICAL-PHARMACOLOGY OF HEPATIC ARTERIAL INFUSIONS OF 5-BROMO-2'- DEOXYURIDINE | 1 | 6 |
| 2353 | 9 | 46 | 9023 1994 CANCER RESEARCH 54 (10): 2701-2706 CHI KH; KUNUGI KA; KINSELLA TJ IODODEOXYURIDINE CHEMOSENSITIZATION OF CIS-DIAMMINEDICHLOROPLATINUM(II) IN HUMAN BLADDER-CANCER CELLS | 0 | 2 |
| 2354 | 14 | 23 | 9024 1994 CANCER RESEARCH 54 (11): 2964-2968 LAWRENCE TS; DAVIS MA; STETSON PL; MAYBAUM J; ENSMINGER WD KINETICS OF BROMODEOXYURIDINE ELIMINATION FROM HUMAN COLON-CANCER CELLS IN-VITRO AND IN-VIVO | 4 | 13 |
| 2355 | 7 | 47 | 9025 1994 CANCER RESEARCH 54 (14): 3772-3778 PRESSACCO J; HEDLEY DW; ERLICHMAN C ICI-D1694 AND IDOXURIDINE - A SYNERGISTIC ANTITUMOR COMBINATION | 1 | 13 |
| 2356 | 2 | 17 | 9171 1995 CANCER RESEARCH 55 (18): 4023-4028 RONINSON IB; GUDKOV AV; HOLZMAYER TA; KIRSCHLING DJ; KAZAROV AR; et al. GENETIC SUPPRESSOR ELEMENTS - NEW TOOLS FOR MOLECULAR ONCOLOGY - 13TH CORNELIUS-P-RHOADS-MEMORIAL-AWARD-LECTURE | 0 | 28 |
| 2357 | 6 | 9 | 9336 1996 CANCER RESEARCH 56 (11): 2677-2678 Knol JA; Lawrence TS; Ensminger WD; Stetson PL; Walker SC; et al. Untitled - Reply | 0 | 0 |
| 2358 | 6 | 206 | 9337 1996 CANCER RESEARCH 56 (24): 5533-5546 Kohn KW Beyond DNA cross-linking: History and prospects of DNA-targeted cancer treatment - Fifteenth Bruce F. Cain memorial award lecture | 0 | 41 |
| 2359 | 28 | 64 | 9581 1998 CANCER RESEARCH 58 (3): 453-461 Warren AJ; Maccubbin AE; Hamilton JW Detection of mitomycin C-DNA adducts in vivo by P-32-postlabeling: Time coarse for formation and removal of adducts and biochemical modulation | 4 | 19 |
| 2360 | 9 | 30 | 9582 1998 CANCER RESEARCH 58 (13): 2793-2800 Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; et al. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: Flow cytometric and pharmacokinetic analysis | 1 | 3 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2361 | 6 | 66 | 9775 2000 CANCER RESEARCH 60 (21): 6080-6088 Ostruszka LJ; Shewach DS The role of cell cycle progression in radiosensitization by 2 ',2 '- difluoro-2 '-deoxycytidine | 1 | 37 |
| 2362 | 21 | 46 | 9827 2001 CANCER RESEARCH 61 (21): 7770-7776 Baumann RP; Hodnick WF; Seow HA; Belcourt MF; Rockwell S; et al. Reversal of mitomycin C resistance by overexpression of bioreductive enzymes in Chinese hamster ovary cells | 3 | 10 |
| 2363 | 6 | 33 | 9828 2001 CANCER RESEARCH 61 (21): 7971-7977 Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; et al. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine | 0 | 11 |
| 2364 | 6 | 31 | 9949 2003 CANCER RESEARCH 63 (18): 5707-5711 Kyle AH; Huxham LA; Baker JHE; Burston HE; Minchinton AI Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent | 0 | 2 |
| 2365 | 6 | 54 | 6944 1984 CANCER SURVEYS 3 (2): 335-350 STANBRIDGE EJ GENETIC-ANALYSIS OF TUMORIGENICITY IN HUMAN CELL HYBRIDS | 0 | 31 |
| 2366 | 3 | 45 | 7225 1985 CANCER SURVEYS 4 (3): 517-528 SUMMERS WC; SARKAR SN; GLAZER PM DIRECT AND INDUCIBLE MUTAGENESIS IN MAMMALIAN-CELLS | 0 | 5 |
| 2367 | 4 | 35 | 7887 1988 CANCER SURVEYS 7 (2): 239-250 BODMER W SOMATIC-CELL GENETICS AND CANCER | 0 | 13 |
| 2368 | 7 | 48 | 7888 1988 CANCER SURVEYS 7 (2): 251-265 GOODFELLOW PN; PRITCHARD CA CHROMOSOME FRAGMENTATION BY CHROMOSOME MEDIATED GENE-TRANSFER | 0 | 3 |
| 2369 | 8 | 52 | 8299 1990 CANCER SURVEYS 9 (3): 475-485 WEISSMAN BE GENETIC BEHAVIOR OF TUMORIGENICITY IN HUMAN CANCER | 0 | 5 |
| 2370 | 1 | 12 | 4278 1976 CANCER TREATMENT REPORTS 60 (1): 99-102 JOHNSON RK; OVEJERA AA; GOLDIN A ACTIVITY OF ANTHRACYCLINES AGAINST AN ADRIAMYCIN (NSC-123127)-RESISTANT SUBLINE OF P388 LEUKEMIA WITH SPECIAL EMPHASIS ON CINERUBIN-A (NSC-18334) | 2 | 76 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2371 | 7 | 38 | 5279 1979 CANCER TREATMENT REPORTS 63 (1): 43-51 SORACE RA; SHEID B CYTOTOXIC EFFECTS OF THE LYSOSOMOTROPIC AGENTS DNA-ELLIPTICINE, DNA-DAUNORUBICIN, AND DNA-ELLIPTICINE - DAUNORUBICIN ON L1210-LEUKEMIA CELLS | 0 | 5 |
| 2372 | 3 | 47 | 5950 1981 CANCER TREATMENT REPORTS 65: 3-8 DIMARCO A; CASSINELLI G; ARCAMONE F THE DISCOVERY OF DAUNORUBICIN | 0 | 10 |
| 2373 | 5 | 17 | 6600 1983 CANCER TREATMENT REPORTS 67 (12): 1079-1084 FUJIWARA K; SAIKUSA H; KITAGAWA T; TAKAHASHI S; KONISHI Y SPECIFICITY OF ANTISERA PRODUCED AGAINST MITOMYCIN-C | 2 | 6 |
| 2374 | 2 | 97 | 6945 1984 CANCER TREATMENT REPORTS 68 (1): 101-115 ENSMINGER WD; GYVES JW REGIONAL CANCER-CHEMOTHERAPY | 5 | 109 |
| 2375 | 4 | 37 | 6946 1984 CANCER TREATMENT REPORTS 68 (1): 291-302 PHILLIPS TL; WASSERMAN TH PROMISE OF RADIOSENSITIZERS AND RADIOPROTECTORS IN THE TREATMENT OF HUMAN CANCER | 5 | 32 |
| 2376 | 12 | 275 | 3917 1975 CANCER TREATMENT REVIEWS 2 (1): 1-31 JOHNSON RK; GOLDIN A CLINICAL IMPACT OF SCREENING AND OTHER EXPERIMENTAL TUMOR STUDIES | 0 | 41 |
| 2377 | 12 | 152 | 4279 1976 CANCER TREATMENT REVIEWS 3 (3): 121-139 CROOKE ST; BRADNER WT MITOMYCIN-C - REVIEW | 70 | 406 |
| 2378 | 9 | 41 | 5618 1980 CANCER TREATMENT REVIEWS 7 (1): 17-27 IGNOFFO RJ; FRIEDMAN MA THERAPY OF LOCAL TOXICITIES CAUSED BY EXTRAVASATION OF CANCER CHEMOTHERAPEUTIC DRUGS | 3 | 79 |
| 2379 | 1 | 42 | 5951 1981 CANCER TREATMENT REVIEWS 8 (1): 51-61 SUGAHARA T; NAKATSUGAWA S RADIATION SENSITIZATION STUDIES IN JAPAN | 0 | 1 |
| 2380 | 2 | 39 | 8300 1990 CANCER TREATMENT REVIEWS 17: 67-79 SCHEULEN ME DEVELOPMENT OF DRUG DERIVATIVES WITHOUT CROSS-RESISTANCE TO PARENT COMPOUNDS | 0 | 1 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2381 | 1 | 56 | 8301 1990 CARBOHYDRATE POLYMERS 13 (2): 185-206 BILIADERIS CG; SENEVIRATNE HD ON THE SUPERMOLECULAR STRUCTURE AND METASTABILITY OF GLYCEROL MONOSTEARATE AMYLOSE COMPLEX | 0 | 36 |
| 2382 | 1 | 28 | 3194 1973 CARBOHYDRATE RESEARCH 28 (2): 263-280 HASKELL TH; RODEBAUG.R; PLESSAS N; WATSON D; WESTLAND RD PREPARATION AND BIOLOGICAL-ACTIVITY OF NOVEL AMINO-ACID ANALOGS OF BUTIROSIN | 0 | 32 |
| 2383 | 1 | 20 | 4631 1977 CARBOHYDRATE RESEARCH 55 (MAY): 73-82 BUTLER NA; LEE EYC; WHELAN WJ PROTEIN-BOUND GLYCOGEN COMPONENT OF RAT-LIVER | 0 | 34 |
| 2384 | 2 | 14 | 7889 1988 CARBOHYDRATE RESEARCH 178: 314-319 CREETH JM OXIDATION-PRODUCTS OF OVARIAN-CYST MUCINS - CHARACTERIZATION BY DENSITY-GRADIENT ANALYSIS | 0 | 0 |
| 2385 | 6 | 60 | 5619 1980 CARCINOGENESIS 1 (10): 837-848 MOREAU PL; FANICA M; DEVORET R CLEAVAGE OF LAMBDA-REPRESSOR AND INDUCTION OF RECA PROTEIN-SYNTHESIS ELICITED BY AFLATOXIN B-1 METABOLITES IN ESCHERICHIA-COLI | 0 | 19 |
| 2386 | 8 | 22 | 5952 1981 CARCINOGENESIS 2 (10): 981-990 KUBINSKI H; KUBINSKI ZO; FIANDT M; KONOPA G FORMATION OF MACROMOLECULAR COMPLEXES AND OTHER EFFECTS OF DNA TREATMENT WITH DIETHYL AND DIMETHYL SULFATE - PHYSICOCHEMICAL AND ELECTRON-MICROSCOPIC STUDIES | 0 | 2 |
| 2387 | 2 | 25 | 6296 1982 CARCINOGENESIS 3 (12): 1481-1485 FRIEDMAN E; CARNRIGHT K; LIPKIN M DIFFERENTIAL RESPONSE OF FAMILIAL POLYPOSIS FIBROBLASTS TO 2 BIFUNCTIONAL ALKYLATING-AGENTS | 0 | 11 |
| 2388 | 3 | 21 | 6601 1983 CARCINOGENESIS 4 (7): 795-798 NAGASAWA H; LITTLE JB SUPPRESSION OF CYTO-TOXIC EFFECT OF MITOMYCIN-C BY SUPEROXIDE-DISMUTASE IN FANCONIS ANEMIA AND DYSKERATOSIS CONGENITA FIBROBLASTS | 3 | 41 |
| 2389 | 2 | 58 | 7226 1985 CARCINOGENESIS 6 (1): 37-44 WESTRA JG; FLAMMANG TJ; FULLERTON NF; BELAND FA; WEIS CC; et al. FORMATION OF DNA ADDUCTS INVIVO IN RAT-LIVER AND INTESTINAL EPITHELIUM AFTER ADMINISTRATION OF THE CARCINOGEN 3,2'-DIMETHYL-4-AMINOBIPHENYL AND ITS HYDROXAMIC ACID | 0 | 34 |
| 2390 | 9 | 29 | 7227 1985 CARCINOGENESIS 6 (2): 271-277 SMITH BA; GUTMANN HR; SPRINGFIELD JR INTERACTION OF NUCLEOPHILES WITH THE ENZYMATICALLY-ACTIVATED CARCINOGEN, N-HYDROXY-2-ACETYLAMINOFLUORENE, AND WITH THE MODEL ESTER, N-ACETOXY-2-ACETYLAMINOFLUORENE | 4 | 17 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 2391 | 2 | 14 | 7228 1985 CARCINOGENESIS 6 (6): 929-931 GRDINA DJ; NAGY B; HILL CK; WELLS RL; PERAINO C THE RADIOPROTECTOR WR1065 REDUCES RADIATION-INDUCED MUTATIONS AT THE HYPOXANTHINE-GUANINE PHOSPHORIBOSYL TRANSFERASE LOCUS IN V79 CELLS | 3 | 95 |
| 2392 | 10 | 52 | 7229 1985 CARCINOGENESIS 6 (7): 1037-1045 LAI CC; MILLER JA; MILLER EC; LIEM A N-SULFOOXY-2-AMINOFLUORENE IS THE MAJOR ULTIMATE ELECTROPHILIC AND CARCINOGENIC METABOLITE OF N-HYDROXY-2-ACETYLAMINOFLUORENE IN THE LIVERS OF INFANT MALE C57BL/6J X C3H-HEJ F1 (B6C3F1) MICE | 4 | 105 |
| 2393 | 7 | 19 | 7230 1985 CARCINOGENESIS 6 (11): 1635-1640 VANDENGOORBERGH JAM; MEERMAN JHN; DEWIT H; MULDER GJ REACTION OF 2-ACETYLAMINOFLUORENE-N-SULFATE WITH RNA AND GLUTATHIONE - EVIDENCE FOR THE GENERATION OF .2. REACTIVE INTERMEDIATES WITH DIFFERENT REACTIVITIES TOWARDS RNA AND GLUTATHIONE | 0 | 20 |
| 2394 | 11 | 33 | 7466 1986 CARCINOGENESIS 7 (3): 405-411 SMITH BA; SPRINGFIELD JR; GUTMANN HR INTERACTION OF THE SYNTHETIC ULTIMATE CARCINOGENS, N-SULFONOXY-2-ACETYLAMINOFLUORENE AND N-ACETOXY-2-ACETYLAMINOFLUORENE, AND OF ENZYMATICALLY ACTIVATED N-HYDROXY-2-ACETYLAMINOFLUORENE WITH NUCLEOPHILES | 6 | 34 |
| 2395 | 3 | 17 | 7467 1986 CARCINOGENESIS 7 (4): 665-668 HILL CK; NAGY B; PERAINO C; GRDINA DJ 2-[(AMINOPROPYL)AMINO]ETHANETHIOL (WR1065) IS ANTINEOPLASTIC AND ANTIMUTAGENIC WHEN GIVEN DURING CO-60 GAMMA-RAY IRRADIATION | 2 | 46 |
| 2396 | 4 | 19 | 7679 1987 CARCINOGENESIS 8 (2): 275-279 VANDENGOORBERGH JAM; DEWIT H; TIJDENS RB; MULDER GJ; MEERMAN JHN PREVENTION BY THIOETHERS OF THE HEPATOTOXICITY AND COVALENT BINDING TO MACROMOLECULES OF N-HYDROXY-2-ACETYLAMINOFLUORENE AND ITS SULFATE ESTER IN RAT-LIVER INVIVO AND INVITRO | 0 | 11 |
| 2397 | 3 | 20 | 8302 1990 CARCINOGENESIS 11 (9): 1563-1567 MANGOLD BLK; ERICKSON J; LOHR C; MCCANN DJ; MANGOLD JB SELF-CATALYZED IRREVERSIBLE INACTIVATION OF RAT HEPATIC ARYL SULFOTRANSFERASE-IV BY N-HYDROXY-2-ACETYLAMINOFLUORENE | 2 | 8 |
| 2398 | 4 | 47 | 8303 1990 CARCINOGENESIS 11 (10): 1869-1873 TSUTSUI T; BARRETT JC SODIUM BISULFITE INDUCES MORPHOLOGICAL TRANSFORMATION OF CULTURED SYRIAN-HAMSTER EMBRYO CELLS BUT LACKS THE ABILITY TO INDUCE DETECTABLE GENE-MUTATIONS, CHROMOSOME MUTATIONS OR DNA DAMAGE | 0 | 7 |
| 2399 | 10 | 41 | 8662 1992 CARCINOGENESIS 13 (10): 1699-1703 GILISSEN RAHJ; RINGER DP; STAVENUITER HJFC; MULDER GJ; MEERMAN JHN SULFATION OF HYDROXYLAMINES AND HYDROXAMIC ACIDS IN LIVER CYTOSOL FROM MALE AND FEMALE RATS AND PURIFIED ARYL SULFOTRANSFERASE-IV | 0 | 17 |
| 2400 | 3 | 33 | 629 1963 CARYOLOGIA 16 (2): 353-& LEVIS AG; COLUSSI M CARATTERISTICHE DI CLONI ISOLATI DOPO TRATTAMENTO CON UNA IPRITE AZOTATA DA UN CEPPO DI CELLULE DI CAVIA COLTIVATE IN VITRO | 1 | 4 |
Page 24 of 102: 1 11 [ 21 22 23 24 25 26 27 28 29 30 ] 31 41 51 61 71 81 91 | 101
Generated by: HistCite 2005.08.29